Abstract:Background Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) is a reliable treatment for actinic keratosis (AK), but its effect needs to be enhanced in thick lesions. Plum-blossom needle is a traditional Chinese cost-effective instrument for enhancing the transdermal delivery of ALA. However, whether it could improve the efficacy of AK treatment has not yet been investigated. Objective To compare the efficacy and safety of plum-blossom needle–assisted PDT in facial AK in the Chinese population. Methods In this multicenter, prospective study, a total of 142 patients with AKs (grades I–III) were randomized into the plum-blossom needle–assisted PDT group (P-PDT) and control PDT group (C-PDT). In the P-PDT group, each AK lesion was tapped vertically by a plum-blossom needle before the application of 10% ALA cream. In the C-PDT group, each lesion was only wiped with regular saline before ALA cream incubation. Then, 3 hours later, all the lesions were irradiated with light-emitting diode (LED) at a wavelength of 630 nm. PDT was performed once every 2 weeks until all lesion patients achieved complete remission or completed six sessions. The efficacy (lesion response) and safety (pain scale and adverse events) in both groups were evaluated before each treatment and at every follow-up visit at 3-month intervals until 12 months. Results In the P-PDT and C-PDT groups, the clearance rates for all AK lesions after the first treatment were 57.9% and 48.0%, respectively ( P < 0.05). For grade I AK lesions, the clearance rates were 56.5% and 50.4%, respectively ( P = 0.34). For grade II AK lesions, the clearance rates were 58.0% and 48.9%, respectively ( P = 0.1). For grade III AK lesions, the clearance rates were 59.0% and 44.2%, respectively ( P < 0.05). Moreover, grade III AK lesions in the P-PDT group required fewer treatment sessions ( P < 0.05). There was no significant difference in the pain score between the two groups ( P = 0.752). Conclusion Plum-blossom needle tapping may enhance the efficacy of ALA-PDT by facilitating ALA delivery in the treatment of AK.

5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study

Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis

Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis

Conventional Versus Daylight Photodynamic Therapy for Actinic Keratosis: A Randomized and Prospective Study in China

Modified Painless Photodynamic Therapy for Actinic Keratosis in China

Modified painless photodynamic therapy for facial multiple actinic keratosis in China: A prospective split‐face control study

Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis

Assessment of 5‐aminolaevulinic Acid Photodynamic Therapy (ALA‐PDT) in Chinese Patients with Actinic Keratosis: Correlation of Dermoscopic Features with Histopathology

5-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an Italian study in the real-life setting

Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study

Advances in Photodynamic Therapy for the Treatment of Actinic Keratosis and Nonmelanoma Skin Cancer: A Narrative Review

A Combination of Laser-Assisted ALA-PDT for Squamous Cell Carcinoma in Situ and Field-Directed ALA-PDT for Actinic Keratosis.

Chinese Guidelines on the Clinical Application of 5-Aminolevulinic Acid-Based Photodynamic Therapy in Dermatology (2021 Edition)

Long-term Improvement on Photoaging after ALA Photodynamic Therapy for Actinic Keratosis: A Retrospective Study.

Efficacy and safety of microneedling, fractional CO2 laser, and cryotherapy combined with 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis: A multicenter prospective randomized controlled study

Comparison of Efficacy, Adverse Effects and Costs Between 20 % ALA-PDT and 10 % ALA-PDT for the Treatment of Actinic Keratosis in Chinese Patients

Clinical effect and safety of 5-aminolevulinic acid photodynamic therapy in the treatment of nose actinic keratosis

Progess of Photodynamic Therapy in the Treatment of Actinic Keratosis

Inflammation burst after 5-aminolevulinic acid-photodynamic therapy for the treatment of actinic keratosis complicating rosacea: A case report

Topical 5-Aminolevulinic Acid-Mediated Photodynamic Therapy for Oral Verrucous Hyperplasia, Oral Leukoplakia and Oral Erythroleukoplakia

Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study